Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M C Besag

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Drug Safety|July 14, 2010
Vigabatrin: an antiepileptic drug with major benefits but significant adverse effectsFrank M C Besag
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 23, 2002
Childhood epilepsy in relation to mental handicap and behavioural disordersFrank M C Besag
Drug Safety|October 9, 2009
Attention-deficit hyperactivity disorder (ADHD) treatment and sudden deathFrank M C Besag
Developmental Medicine and Child Neurology|April 17, 2012
Psychopathological outcome of extratemporal lobe surgery: the need for international collaboration on data collectionFrank M C Besag
Epilepsia|March 21, 2002
When is it inappropriate to prescribe psychotropic medication?Frank M C Besag
Expert Opinion on Pharmacotherapy|February 26, 2011
Rufinamide for the treatment of Lennox-Gastaut syndromeFrank M C Besag
Evidence-Based Medicine|November 26, 2016
Rate of epilepsy in people with autism and the rate of autism in people with epilepsy are highFrank M C Besag
Drug Safety|May 6, 2014
ADHD treatment and pregnancyFrank M C Besag
Seizure|November 3, 2004
The Department of Health Action Plan "Improving Services for People with Epilepsy": a significant advance or only a first step?Frank M C Besag
Epilepsia|November 16, 2006
Cognitive and behavioral outcomes of epileptic syndromes: implications for education and clinical practiceFrank M C Besag
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Drug Safety|July 14, 2010
Vigabatrin: an antiepileptic drug with major benefits but significant adverse effectsFrank M C Besag
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 23, 2002
Childhood epilepsy in relation to mental handicap and behavioural disordersFrank M C Besag
Drug Safety|October 9, 2009
Attention-deficit hyperactivity disorder (ADHD) treatment and sudden deathFrank M C Besag
Developmental Medicine and Child Neurology|April 17, 2012
Psychopathological outcome of extratemporal lobe surgery: the need for international collaboration on data collectionFrank M C Besag
Epilepsia|March 21, 2002
When is it inappropriate to prescribe psychotropic medication?Frank M C Besag
Expert Opinion on Pharmacotherapy|February 26, 2011
Rufinamide for the treatment of Lennox-Gastaut syndromeFrank M C Besag
Evidence-Based Medicine|November 26, 2016
Rate of epilepsy in people with autism and the rate of autism in people with epilepsy are highFrank M C Besag
Drug Safety|May 6, 2014
ADHD treatment and pregnancyFrank M C Besag
Seizure|November 3, 2004
The Department of Health Action Plan "Improving Services for People with Epilepsy": a significant advance or only a first step?Frank M C Besag
Epilepsia|November 16, 2006
Cognitive and behavioral outcomes of epileptic syndromes: implications for education and clinical practiceFrank M C Besag
Pageof 9